Notably, positive correlations were found with dendritic cells, CD4+ T cells, and neutrophils, suggesting that TGFBR2 may play a significant role in enhancing the immune regulatory network within the LUAD tumor microenvironment. Here, TGFBR2 is linked to neoplasm.